TYPE 1 DIABETES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Type 1 Diabetes Market, By Device Type (Insulin Pen, Insulin Syringe, Insulin Pump, Insulin Jet Injectors), By Insulin Type (Long-Acting Insulin, Rapid-Acting Insulin), By End User (Homecare Settings, Hospitals & Clinics, Academic & Research Institutes, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Mar 2024
Code : CMI6791
Pages :165
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Type 1 Diabetes Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Advancements in insulin delivery technologies

Technological advancement is another key factor contributing to the growth of the type 1 diabetes market. Insulin injections via syringes were the standard method of treatment. However, continuous subcutaneous insulin infusion via insulin pumps and smart insulin pens have significantly improved diabetes management in recent years. These modern insulin delivery devices automatically provide small doses of insulin continuously throughout the day to mimic the body's natural insulin release. Compared to multiple daily injections, insulin pumps are more convenient to use and allow for better blood glucose control. Newer pump models can be remotely controlled via companion apps on smartphones and connected to continuous glucose monitoring systems for added precision. Similarly, smart insulin pens that record dosing information are gaining widespread acceptance. These provide tracking of insulin on board which is helpful for determining correct bolus doses during meals or illness.

Key Players Insights